http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004096218-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_072484bc2b6b0d45ec91734f0e8fc98b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11b820f9b2d62792d9e4d5ef2975b2fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1f1f5b41d8205d7551b1990e4c116b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1543645bfc2476fdcda2a0d51fc956fa |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2004-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c0ecd16ea6fd224ba41c1f964c1b584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c14d717d33015c049b65ed6a72848886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20dc56f89a35bf05f446a7e19692d4d2 |
| publicationDate | 2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004096218-A3 |
| titleOfInvention | Pellet formulations of acid-labile antiulcer benzimidazole compounds |
| abstract | They comprise inert granules of sugar/starch which are: initially coated with a non-alkaline active layer having the benzimidazole compound (omeprazole, lansoprazole, pantoprazole, rabeprazole, etc.), sodium and/potassium salts of acids of formula R-O-SO3H wherein R is an alkyl radical of a (C6-C20)-fatty acid (preferably sodium lauryl sulfate), (C6-C20)-fatty acids (preferably oleic acid), sodium and/or potassium salts Of (C6-C20)-fatty acids (preferably potassium oleate), sodium carboxymethyl starch and polyvinylpyrrolidone; secondly coated with a non-alkaline barrier layer having hydroxypropylmethylcellulose; and finally coated with an enteric layer. The preferred molar ratio (sodium lauryl sulfate):(oleic acid + potassium oleate) is between 4:1 and 6:1. All coatings are done with aqueous solutions, suspensions or dispersions at a relatively high temperature, and all dryings are done at a relatively low temperature and for a relatively short time. They are stable over time and useful for oral administration. |
| priorityDate | 2003-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.